A Phase Ⅰ Single-center, Blind, Randomized, Placebo-Controlled Study to Examine the Safety and Immunogenicity of a Hexavalent BRV Vaccine in Healthy Subjects( 6weeks)
Latest Information Update: 15 Jul 2016
At a glance
- Drugs Rotavirus vaccine (Primary)
- Indications Rotavirus infections
- Focus Adverse reactions
- Sponsors Wuhan Institute of Biological Products
- 15 Jul 2016 New trial record